PD‐1 inhibitor‐related pneumonitis in lymphoma patients treated with single‐agent pembrolizumab therapy

E-ISSN： 1365-2141|180|5|752-755

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.180, Iss.5, 2018-03, pp. : 752-755

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Looking for the best immune‐checkpoint inhibitor in pre‐treated NSCLC patients: An indirect comparison between nivolumab, pembrolizumab and atezolizumab

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 6, 2018-03 ,pp. : 1277-1284

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nedaplatin as a Single-Agent Chemotherapy May Support Palliative Therapy for Patients with Adenoid Cystic Carcinoma: A Case Report

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-08 ,pp. : 783-789

Karger

Access to resources Recommend Favorite

Single-Agent Gemcitabine Is Active in Previously Treated Metastatic Breast Cancer

Oncology, Vol. 60, Iss. 4, 2001-06 ,pp. : 303-307

Karger

Access to resources Recommend Favorite

Cisplatin as Single-Agent Chemotherapy in Patients with Liver Dysfunction Due to Metastases

Oncology Research and Treatment, Vol. 32, Iss. 7, 2009-06 ,pp. : 400-404

Karger

Access to resources Recommend Favorite

Electroacupuncture for fatigue, sleep, and psychological distress in breast cancer patients with aromatase inhibitor‐related arthralgia: A randomized trial

CANCER, Vol. 120, Iss. 23, 2014-12 ,pp. : 3744-3751

John Wiley & Sons Inc

Access to resources Recommend Favorite